Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis

Diabetic Medicine

Volumn 30, Issue 11, 2013, Pages 1388-1389

  Meyer, L ^a   Chantrel, F ^b   Imhoff, O ^c   Sissoko, A ^b   Serb, L ^b   Dorey, F ^d   Fleury, D ^d   Smagala, A ^e   Kepenekian, L ^a   Krummel, T ^a   Le Floch, J P ^f   Kessler, L ^a  

^a HÔPITAL CIVIL   (France)

^b Mulhouse Hospital   (France)

^c Department of Hematology   (France)

^d CENTRE HOSPITALIER DE VALENCIENNES   (France)

^e Civil Hospital   (France)

^f Department of Diabetology   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN DETEMIR;

AGED; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTERSTITIAL FLUID; LETTER; MALE; MEAL; MONITOR; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 84885910053     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12294     Document Type: Letter

References (5)

1. Kalantar-Zadeh K. A critical evaluation of glycated protein parameters in advanced nephropathy: a matter of life or death: A1C remains the gold standard outcome predictor in diabetic dialysis patients. Diabetes Care 2012; 35: 1625-1628.
2. Freedman BI. A critical evaluation of glycated protein parameters in advanced nephropathy: a matter of life or death: time to dispense with the hemoglobin A1C in end-stage kidney disease. Diabetes Care 2012; 35: 1621-1624.
3. 1c-based equation to estimate blood glucose in maintenance hemodialysis patients. Diabetes Care 2013; 36: 922-927.
4. Shafi T, Sozio SM, Plantinga LC, Jaar BG, Kim ET, Parekh RS et al. Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients. Diabetes Care 2012; 36: 1522-1533.
5. Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology 2012; 17: 182-188.